|
...
The initial clinical is a double-blind, placebo-controlled study designed to compare the efficacy and safety of four different dosage strengths of Q8003IR...
NOTE: All illustrations and photos
have been removed from this article.
More articles from Worldwide Biotech
MARKETING APPLICATION FOR VORINOSTAT FILED IN EUROPE., January 01, 2008
OASMIA PHARMACEUTICAL SIGNS LICENSING PACT WITH ORION., January 01, 2008
FOVEA/GENZYME SIGN OPHTHALMOLOGY RESEARCH PACT., January 01, 2008
HEALTH CANADA ACCEPTS SANTHERA'S NDS FOR SNT-MC17., January 01, 2008
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
